A new report shows up to 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, an increase of about 300,000 cases.

The President Donald Trump administration's request for Novavax Inc. to conduct new clinical trials for its COVID-19 vaccine has created uncertainty across the vaccine industry, potentially affecting ...

CNBC's Megan Cassella joins 'Closing Bell Overtime' to tallk the latest from the Federal Reserve. News Center 7 uncovered a ...

The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

As Donald Trump completes the first 100 days of his second term, the consequences of his early health care decisions are ...

In a recent interview, FDA Commissioner Marty Makary said there “should be nothing political about the FDA.” Recent actions ...

Novavax is working with the FDA to meet additional requirements and hopes to secure full approval as soon as possible.

The Food and Drug Administration (FDA) suspended a quality-control testing program for drinking milk and other dairy products ...

If the goal of these cuts was to make the government leaner, the result has been to make it weaker. And in the realm of public health, weakness can be deadly.

WASHINGTON (AP) — The White House on Monday opened a weeklong celebration of Donald Trump’s first 100 days in office by ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

Osaic chief market strategist Phil Blancato joins 'Making Money' to discuss the impact of consumer behavior on the stock ...